Cat# NEZ030005MC; Chromium-51 Radionuclide Sodium chromate in normal saline, 5mCi, Quote#: Q-129559

Revvity Health Sciences, Inc. has been awarded a contract by the University of Virginia, a contracting organization in Virginia, effective August 8, 2026. The contract carries a cumulative value of $1,056.96 and encompasses the supply of medical-grade radionuclide materials. The prime contractor will deliver Chromium-51 Radionuclide Sodium chromate in normal saline at a concentration of 5 millicuries per unit, with a total quantity of 1,056 units ordered at a unit price of $1.00 each.

This procurement supports the University of Virginia's medical and research operations through the provision of diagnostic radiopharmaceutical materials. The contract line item references Quote #Q-129559 and specifies delivery to the buyer, with the materials identified by catalog number NEZ030005MC. As a specialty pharmaceutical product requiring regulatory compliance and proper handling procedures, the radionuclide sodium chromate is intended for clinical or research applications within the University of Virginia's healthcare or scientific programs.